In this regard, neuroserpin, another member of the serpin family has been already tested as an adjuvant therapy for tissue-type plasminogen activator administration in a rat model of embolic stroke demonstrating neuroprotective effects [27], but the therapeutic potential of SERPINE-1, SERPINB1 or SERPINB9 is still unknown. Here, SERPINI1 is linked to stroke disorder.